• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    RadNet Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    5/12/25 9:03:42 AM ET
    $RDNT
    Medical Specialities
    Health Care
    Get the next $RDNT alert in real time by email
    RadNet, Inc. 8-K
    false 0000790526 0000790526 2025-05-11 2025-05-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 8-K

     

     

     

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported) May 11, 2025

     

    RadNet, Inc.

    (Exact name of registrant as specified in its charter)

     

    Delaware   001-33307   13-3326724
    (State or other jurisdiction
    of incorporation)
      (Commission File Number)   (IRS Employer Identification No.)

     

    1510 Cotner Avenue    
    Los Angeles, California   90025
    (Address of Principal Executive Offices)   (Zip Code)

      

    Registrant’s Telephone Number, Including Area Code: (310) 445-2800

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☒Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

    Trading Symbol(s) Name of each exchange on which registered
    Common Stock, $0.0001 par value RDNT NASDAQ

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

       

     

     

    Item 2.02RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

     

    On May 11, 2025 RadNet, Inc. (“RadNet”) issued a press release regarding its financial results for the first quarter ended March 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

     

    The information in this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

     

    Item 9.01FINANCIAL STATEMENTS AND EXHIBITS.

     

    (d) Exhibits

     

    Exhibit No. Description
       
    99.1

    Press Release dated May 12, 2025 relating to RadNet, Inc.’s financial results for the quarter ended March 31, 2025.

    104 Cover Page Interactive Data File (embedded within the inline XBRL document)

     

     

     

     

     

     

     2 

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: May 12, 2025 RADNET, INC.  
         
           
      By: /s/ Mark Stolper  
      Mark Stolper  
      Chief Financial Officer  

     

     

     

     

     

     

     

     

     

     

     

     3 

    Get the next $RDNT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RDNT

    DatePrice TargetRatingAnalyst
    6/13/2025$69.00Buy
    B. Riley Securities
    3/5/2025$85.00 → $65.00Outperform → Strong Buy
    Raymond James
    9/6/2024$57.00 → $79.00Equal Weight → Overweight
    Barclays
    3/6/2024$48.00Equal Weight
    Barclays
    8/31/2023$40.00Buy
    Truist
    3/31/2023$30.00Market Outperform
    CJS Securities
    3/3/2023$30.00Mkt Perform → Outperform
    Raymond James
    8/12/2021Outperform → Market Perform
    Raymond James
    More analyst ratings

    $RDNT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AI Healthcare Funding Surges as Real-World Rollouts Hit Pharmacies, Hospitals, and Providers

      Equity Insider News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 17, 2025 /PRNewswire/ -- Venture Capital continues to flow in bunches into the AI in healthcare sector, with AI companies capturing more than half of digital health funding in Q1. Investors are seeking novel opportunities that tap into this space, with private companies such as Ellipsis Health and Autonomize AI recently receiving $45M and $28M respectively for their innovations. For other investors seeking opportunities among publicly traded companies, there's been plenty of development to follow from innovators, including from Avant Technologies, Inc. (OTCQB:AVAI), IQVIA Holdings Inc. (NYSE:IQV), S

      6/17/25 10:17:00 AM ET
      $CI
      $IQV
      $RDNT
      $SOUN
      Medical Specialities
      Health Care
      Biotechnology: Commercial Physical & Biological Resarch
      Computer Software: Prepackaged Software
    • RadNet, Inc. Acquires See-Mode Technologies for Innovation in AI-Powered Ultrasound Diagnostics

      See-Mode's commercially available AI-powered ultrasound detection, characterization, and reporting solutions for thyroid and breast will be integrated into RadNet's DeepHealth population health solutionsReal-world deployment of See-Mode's FDA-approved thyroid ultrasound solution at RadNet imaging centers demonstrates improved workflow efficiency and enhanced diagnostic accuracy The acquisition positions RadNet at the forefront of AI innovation in ultrasound LOS ANGELES, June 04, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT) ("RadNet"), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions through its wholly-owned subsidi

      6/4/25 4:01:00 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • RadNet Reports First Quarter Financial Results and Revises Upwards 2025 Financial Guidance Ranges for Revenue and Adjusted EBITDA¹

      First quarter Revenue was negatively impacted by approximately $22 million and Adjusted EBITDA(1) was negatively impacted by approximately $15 million as a result of the Southern California wildfires and severe winter weather conditionsTotal Company Revenue increased 9.2% to $471.4 million in the first quarter of 2025 from $431.7 million in the first quarter of 2024Revenue from the Digital Health reportable segment increased 31.1% to $19.2 million in the first quarter of 2025 from $14.7 million in the first quarter of 2024Aggregate procedural volumes increased 3.6% and same-center procedural volumes decreased 0.3% compared with the first quarter of 2024Total Company Adjusted EBITDA(1) was $4

      5/11/25 4:00:00 PM ET
      $RDNT
      Medical Specialities
      Health Care

    $RDNT
    SEC Filings

    See more
    • RadNet Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - RadNet, Inc. (0000790526) (Filer)

      6/12/25 4:20:27 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • SEC Form EFFECT filed by RadNet Inc.

      EFFECT - RadNet, Inc. (0000790526) (Filer)

      5/22/25 12:15:18 AM ET
      $RDNT
      Medical Specialities
      Health Care
    • SEC Form 424B3 filed by RadNet Inc.

      424B3 - RadNet, Inc. (0000790526) (Filer)

      5/21/25 5:10:55 PM ET
      $RDNT
      Medical Specialities
      Health Care

    $RDNT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • B. Riley Securities initiated coverage on RadNet with a new price target

      B. Riley Securities initiated coverage of RadNet with a rating of Buy and set a new price target of $69.00

      6/13/25 7:50:00 AM ET
      $RDNT
      Medical Specialities
      Health Care
    • RadNet upgraded by Raymond James with a new price target

      Raymond James upgraded RadNet from Outperform to Strong Buy and set a new price target of $65.00 from $85.00 previously

      3/5/25 7:50:00 AM ET
      $RDNT
      Medical Specialities
      Health Care
    • RadNet upgraded by Barclays with a new price target

      Barclays upgraded RadNet from Equal Weight to Overweight and set a new price target of $79.00 from $57.00 previously

      9/6/24 7:50:42 AM ET
      $RDNT
      Medical Specialities
      Health Care

    $RDNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP, Chief Science Officer Sorensen Alma Gregory gifted 5,600 shares, decreasing direct ownership by 0.48% to 1,165,345 units (SEC Form 4)

      4 - RadNet, Inc. (0000790526) (Issuer)

      6/18/25 4:15:24 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • Director Swartz David L was granted 2,699 shares, increasing direct ownership by 2% to 176,766 units (SEC Form 4)

      4 - RadNet, Inc. (0000790526) (Issuer)

      6/11/25 6:58:58 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • Director Spurlock Gregory E. was granted 2,699 shares, increasing direct ownership by 104% to 5,290 units (SEC Form 4)

      4 - RadNet, Inc. (0000790526) (Issuer)

      6/11/25 6:57:48 PM ET
      $RDNT
      Medical Specialities
      Health Care